Early nephropathy predicts vision-threatening retinal disease in patients with type I diabetes mellitus

Journal of the American Society of Nephrology

Volumn 9, Issue 1, 1998, Pages 85-89

  Gilbert, Richard E ^a   Tsalamandris, Con ^a   Allen, Terri J ^a   Colville, Deborah ^a   Jerums, George ^a  

^a AUSTIN HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; GLYCOSYLATED HEMOGLOBIN;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; DIABETIC NEPHROPATHY; FEMALE; HIGH RISK PATIENT; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PRIORITY JOURNAL; PROLIFERATIVE RETINOPATHY; RETINA DISEASE; RETINA MACULA EDEMA; VISUAL DISORDER;

EID: 0031965257     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Lane P, Steffes M, Mauer M: Renal histological changes in diabetes mellitus. Semin Nephrol 10: 254-259, 1990
2. Mogensen CE, Schmitz O: The diabetic kidney: From hyperfiltration and microalbuminuria to end-stage renal failure. Med Clin North Am 72: 1465-1492, 1988
3. Klein R, Klein BEK, Moss SE: Epidemiology of proliferative diabetic retinopathy. Diabetes Care 15: 1875-1891, 1992
4. Barnett AH, Dallinger K, Jennings P, Fleycher J, Odugbesan O: Microalbuminuria and diabetic retinopathy. Lancet I: 53-54, 1985
5. Vigstrup J, Mogensen CE: Proliferative diabetic retinopathy: At risk patients identified by early detection of microalbuminuria. Acta Ophthalmol 63: 530-534, 1985
6. Bilous RW, Viberti GC, Sandahl-Christensen J, Parving H-H, Keen H: Dissociation of diabetic complications in insulin-dependent diabetics: A clinical report. Diabet Nephrol 4: 73-76, 1985
7. Marre M, Bruel D, Passa P: Albuminuria and diabetic retinopathy. Lancer I: 516-517, 1985
8. Agardh E, Tallroth G, Bauer B, Cavallin-Sjöberg U, Agardh C-H: Retinopathy and nephropathy in insulin-dependent diabetics: An inconsistent relationship? Diabet Med 4: 248-250, 1987
9. Mogensen CE: Management of early nephropathy in diabetic patients. Annu Rev Med 46: 79-94, 1995
10. Mogensen CE, Chachati A, Christensen CK, Close C, Deckert T, Hommel E, Kastrup J, Lefebvre P, Mathiesen E, Feldt-Rasmussen B, Schmitz A, Viberti GC: Microalbuminuria: An early marker of renal involvement in diabetes. Uremia Invest 9: 85-95, 1985
11. Christensen C, Mogensen C: Effect of antihypertensive treatment on progression of incipient diabetic nephropathy. Hypertension 7: 109-113, 1985
12. Laffel LM, McGill JB, Gans DJ, for the North American Microalbuminuria Study Group: The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. Am J Med 99: 497-504, 1995
13. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD, for the Collaborative Study Group: The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. N Engl J Med 329: 1456-1462, 1993
14. The Diabetic Retinopathy Study (DRS) Research Group: Preliminary report on effects of photocoagulation therapy. Am J Ophthalmol 81: 383-396, 1976
15. The Diabetic Retinopathy Study Research Group: Photocoagulation treatment of proliferative diabetic retinopathy: The second report of diabetic retinopathy study findings. Ophthalmology 85: 82-106, 1978
16. Early Treatment Diabetic Retinopathy Study Research Group: Early photocoagulation for diabetic retinopathy. ETDRS report no. 9. Ophthalmology 98: 766-785, 1991
17. American Academy of Ophthalmology Quality of Care Committee Retina Panel: Diabetic retinopathy: American Academy of Ophthalmology preferred practice patterns. Am Acad Ophthalmol San Francisco: 1-32, 1993
18. Jerums G, Allen TJ, Cooper ME: Triphasic changes in selectivity with increasing proteinuria in type I and type II diabetes. Diabet Med 6: 772-779, 1989
19. 1. FEBS Lett 71: 356-360, 1976
20. Rizzo T, Metzger BE, Burns WJ, Burns K: Correlations between antepartum maternal metabolism and intelligence of offspring. N Engl J Med 325: 911-916, 1991
21. Gilbert RE, Tsalamandris C, Bach L, Panagiotopoulos S, O'Brien RC, Allen TJ, Goodall I, Seeman E, Cooper ME, Murray R, Jerums G: Glycemic control and the rate of progression of early diabetic kidney disease. Kidney Int 44: 855-859, 1993
22. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE, Nguyen HV, Aiello LM, Ferrara N, King GL: Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331: 1480-1487, 1994
23. Paques M, Massin P, Gaudric A: Growth factors and diabetic retinopathy. Diabetes Metab 23: 125-130, 1997
24. Parving H-H, Hommel E, Mathiesen E, Skøtt P, Edsberg B, Bahnsen M, Lauritzen M, Hougaard P, Lauritzen E: Prevalence of microalbuminuria, arterial hypertension, retinopathy and neuropathy in patients with insulin dependent diabetes. Br Med J 296: 156-160, 1988
25. Klein R, Klein BEK, Moss SE, DeMets DL: Proteinuria and diabetes. Arch Intern Med 148: 181-186, 1988
26. Mogensen CE, Vigstrup J, Ehlers N: Microalbuminuria predicts proliferative diabetic retinopathy. Lancet I: 1512-1513, 1985
27. Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977-986, 1993
28. Lloyd CE, Orchard TJ: Diabetes complications: The renal-retinal link. Diabetes Care 18: 1034-1036, 1995
29. The Diabetes Control and Complications Trial Research Group: The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. Diabetes 44: 968-983, 1995
30. Viberti GC, Bilous RW, Mackintosh D, Bending JJ, Keen H: Long-term correction of hyperglycaemia and progression of renal failure in insulin-dependent diabetes. Br Med J 286: 598-602, 1983
31. Davis MD: Diabetic retinopathy: A clinical review. Diabetes Metab Rev 4: 291-322, 1988
32. Stephenson JM, Fuller JH, Viberti G-C, Sjolie A-K, Navalesi R, for the EURODIAB Insulin-Dependent Diabetes Mellitus Com5plications Study Group: Blood pressure, retinopathy and albumin excretion in IDDM: The EURODIAB IDDM Complications Study. Diabetologia 38: 599-603, 1995
33. Ravid M, Savin H, Jutrin I, Bental T, Katz B, Lishner M: Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients. Ann Intern Med 118: 577-581, 1993